Trial Profile
A Uremic Toxin Absorbent (AST-120) to Treat Hospital Acquired Acute Kidney Injury - A Open Label Randomized Control Trial
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Charcoal (Primary) ; Pentoxifylline
- Indications Acute kidney injury
- Focus Therapeutic Use
- 24 Feb 2016 New trial record